Cell-Free DNA as Biomarker in Oral Squamous Cell Carcinoma: Dynamics, Mutational Landscape and Clinical Implications
Cells · 2026
DOI: 10.3390/cells15060568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Pedro Veiga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cytogenetics and Genomics Laboratory, Institute of Cellular and Molecular Biology, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Port…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Mouth Neoplasms, Cell-Free Nucleic Acids, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a prevalent form of head and neck cancer that typically develops on the lip or within the oral cavity. Although there have been advances in early detection and treatment, the prognosis for patients, particularly those with advanced-stage disease, remains poor. Liquid biopsy, particularly through the analysis of cell-free DNA (cfDNA) in plasma and urine, has emerged as a promising tool for non-invasive cancer detection and monitoring. This study assessed cfDNA concentration dynamics in plasma and urine samples from 32 OSCC patients, with 5 undergoing genomic characterization by targeted next-generation sequencing (NGS). CfDNA levels were higher in patients compared to healthy controls and showed transient increases following treatment initiation, likely reflecting tumor cell death, followed by a gradual return to baseline. However, cfDNA concentrations were not significantly associated with tumor stage, recurrence, or progression-free survival. Targeted NGS analysis revealed a heterogeneous mutational landscape, identifying 76 variants across tumor tissue and initial cfDNA, with 30.3% shared between both sources. Recurrent hotspot mutations were detected in several important genes, including TP53, PIK3CA, KRAS, APC, and FBXW7. Urine cfDNA also captured several mutations absent from plasma or tissue, supporting its complementary value. These findings demonstrate that cfDNA analysis can dynamically reflect treatment response and capture tumor heterogeneity in OSCC. While informative, cfDNA quantification alone offers limited prognostic reliability, reinforcing the need for a multidimensional approach that includes genomic and clinical evaluation. Overall, this study supports the potential of liquid biopsy as a real-time, non-invasive tool for molecular monitoring and personalized management of OSCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cytogenetics and Genomics Laboratory, Institute of Cellular and Molecular Biology, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal.
- Maxillofacial Surgery Department, Unidade Local de Saúde de Coimbra, 3004-561 Coimbra, Portugal.
- Laboratory of Biostatistics and Medical Informatics, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal.
- Center of Investigation on Environment Genetics and Oncobiology (CIMAGO), Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal.
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-531 Coimbra, Portugal.
- Clinical Academic Center of Coimbra (CACC), Hospitais da Universidade de Coimbra, 3004-561 Coimbra, Portugal.
ORCID-Profile: Carolina Mano, Francisco Caramelo, Ilda Patrícia Ribeiro, Joana Barbosa de Melo
Zitieren
APA
Veiga, P., Barroso, L., Pires, L. M., Mano, C., Caramelo, F., Carreira, I. M., Ribeiro, I. P., & de Melo, J. B. (2026). Cell-Free DNA as Biomarker in Oral Squamous Cell Carcinoma: Dynamics, Mutational Landscape and Clinical Implications. Cells. https://doi.org/10.3390/cells15060568
Vancouver
Veiga P, Barroso L, Pires LM, Mano C, Caramelo F, Carreira IM, et al. Cell-Free DNA as Biomarker in Oral Squamous Cell Carcinoma: Dynamics, Mutational Landscape and Clinical Implications. Cells. 2026. doi:10.3390/cells15060568
BibTeX
@article{Veiga2026,
author = {Veiga, Pedro and Barroso, Leonor and Pires, Luís Miguel and Mano, Carolina and Caramelo, Francisco and Carreira, Isabel Marques and Ribeiro, Ilda Patrícia and de Melo, Joana Barbosa},
title = {Cell-Free DNA as Biomarker in Oral Squamous Cell Carcinoma: Dynamics, Mutational Landscape and Clinical Implications},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15060568}
}
EUVIMED